Provided by
| Consensus (mean) in EUR million | FY 2024 | FY 2025 | FY 2026 E | FY 2027 E | FY 2028 E |
|---|---|---|---|---|---|
| Orders received | 5,837 | 5,216 | 5,000 | 5,390 | 5,703 |
| - Biomaterial Solutions and Services | 4,392.0 | 3,716.0 | 3,383.5 | 3,569.0 | 3,789.6 |
| - Process Performance Solutions | 1,446.0 | 1,500.0 | 1,616.6 | 1,821.3 | 1,913.6 |
| Net sales | 5,359 | 5,197 | 5,335 | 5,456 | 5,692 |
| - Biomaterial Solutions and Services | 3,922.0 | 3,716.0 | 3,739.1 | 3,636.6 | 3,749.4 |
| - Process Performance Solutions | 1,437.0 | 1,481.0 | 1,605.5 | 1,799.5 | 1,887.3 |
| Comparable EBITA | 609 | 620 | 625 | 686 | 743 |
| - Biomaterial Solutions and Services | 403.0 | 381.0 | 368.8 | 387.5 | 422.0 |
| - Process Performance Solutions | 255.0 | 290.0 | 308.7 | 346.6 | 368.6 |
| Comparable EBITA Margin (%) | 11.4% | 11.9% | 11.7% | 12.6% | 13.1% |
| - Biomaterial Solns. and Servs. | 10.3% | 10.3% | 9.9% | 10.6% | 11.3% |
| - Process Perf. Solns. | 17.7% | 19.6% | 19.2% | 19.3% | 19.5% |
| Reported EPS | 1.52 | 1.52 | 1.76 | 2.14 | 2.42 |
| Dividend per share | 1.35 | 1.35 | 1.41 | 1.48 | 1.54 |